
CJC-1295 No DAC 5mg + Ipamorelin 5mg supplied as a 10mg lyophilised laboratory research blend. UK-based stock with batch traceability and independent analytical testing programme. Research use only.
In stock
CJC-1295 No DAC and Ipamorelin are synthetic peptides studied in laboratory research involving growth-hormone-axis signalling through distinct receptor pathways. CJC-1295 No DAC is investigated as a GHRH analogue, while Ipamorelin is studied as a growth-hormone secretagogue acting through the ghrelin receptor pathway. Research examines receptor signalling and regulation of growth-hormone release mechanisms. VOREVIA supplies this material strictly for laboratory research and analytical investigation. It is not for human consumption, therapeutic, diagnostic or veterinary use.